Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-26

FDA Approved: CHOLESTYRAMINE — Supplemental Application (EPIC PHARMA, LLC)

View source ↗

Summary

FDA approved a supplemental application for cholestyramine from EPIC PHARMA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholestyramine (cholestyramine)

Snippet

SUPPL AP for CHOLESTYRAMINE (CHOLESTYRAMINE)